Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surely you are joking, Mr Docking!

Chemical Society reviews·2023
Same author

QSAR analysis of the toxicity of nitroaromatics in Tetrahymena pyriformis: structural factors and possible modes of action.

SAR and QSAR in environmental research·2011
Same author

QSAR modeling of GPCR ligands: methodologies and examples of applications.

Ernst Schering Foundation symposium proceedings·2007
Same author

QSAR modeling of datasets with enantioselective compounds using chirality sensitive molecular descriptors.

SAR and QSAR in environmental research·2005
Same author

Accurate classification of protein structural families using coherent subgraph analysis.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2004
Same author

Diversity and coverage of structural sublibraries selected using the SAGE and SCA algorithms.

Journal of chemical information and computer sciences·2001

Related Experiment Video

Updated: Jun 21, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Recent trends in computer-aided drug discovery.

A Tropsha1

  • 1Laboratory for Molecular Modeling, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA. alex_tropsha@unc.edu

Current Opinion in Drug Discovery & Development
|August 4, 2009
PubMed
Summary

Computer-aided drug design is rapidly advancing due to database technology. Modern methods integrate computational tools and bioinformatics for optimal drug-like molecules with improved ADME and toxicity profiles.

Area of Science:

  • Computational chemistry and cheminformatics
  • Bioinformatics and systems biology
  • Pharmacology and toxicology

Background:

  • The field of computer-aided drug design and discovery is rapidly evolving.
  • Expansion in molecular and biomolecular database technology has transformed data processing and exploitation.
  • Established methods are shifting towards optimizing drug-like properties beyond high-affinity binding.

Purpose of the Study:

  • To review recent and developing trends in computer-aided drug design and discovery.
  • To highlight the impact of advances in chemo- and bioinformatics on modern drug discovery.
  • To discuss the paradigm shift towards molecules with optimal ADME and toxicity profiles.

Main Methods:

  • Integration of computational tools in drug design workflows.

Related Experiment Videos

Last Updated: Jun 21, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

  • Leveraging bioinformatics for analyzing molecular and biomolecular data.
  • Utilizing chemoinformatics for structure-activity relationship analysis.
  • Main Results:

    • Significant advancements in storing, processing, and exploiting molecular information.
    • Development of novel computational approaches for drug design.
    • Emergence of drug-like molecules with improved ADME and toxicity characteristics.

    Conclusions:

    • The integration of computational tools and bioinformatics is revolutionizing drug discovery.
    • Modern drug design prioritizes optimal ADME and toxicity properties.
    • Future trends indicate a continued synergy between chemo- and bioinformatics in developing effective therapeutics.